Advertisement

A novel histologic grading system based on lymphovascular invasion, perineural invasion, and tumor budding in colorectal cancer

  • Jung Wook Huh
  • Woo Yong LeeEmail author
  • Jung Kyong Shin
  • Yoon Ah Park
  • Yong Beom Cho
  • Hee Cheol Kim
  • Seong Hyeon Yun
Original Article – Clinical Oncology
  • 35 Downloads

Abstract

Purpose

This study aimed to evaluate the prognostic significance of lymphovascular (LVI), perineural invasion (PNI), and tumor budding positivity in patients with colorectal cancer.

Methods

From January 2008 to December 2011, 3707 consecutive patients who underwent curative surgery for stage I–III colorectal cancer were assessed. These patients were then categorized into four groups based on LVI, PNI, and tumor budding (risk grouping): all negative (n = 1495), 1 + only (n = 1063), 2 + only (n = 861), and all positive (n = 288).

Results

With a median follow-up period of 52 months, the 5-year disease-free survival rates of the risk groups were significantly different in terms of cancer staging (stage I, Stage II, and Stage III: P = 0.006, P < 0.001, and P < 0.001, respectively). In the multivariate analysis, risk grouping was an independent prognostic factor of disease-free survival. Preoperative carcinoembryonic antigen level, tumor size, T category, and N category were independent predictors of LVI, PNI, and tumor budding positivity.

Conclusion

Risk grouping based on LVI, PNI, and tumor budding positivity is a strong predictor of disease-free survival in patients with colorectal cancer.

Keywords

Prognosis Lymphovascular invasion Perineural invasion Tumor budding Colorectal cancer 

Notes

Acknowledgements

This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (grant number 2015R1A1A1A05001160).

Compliance with ethical standards

Conflict of interest

The authors declare no potential conflicts of interest.

References

  1. Blumberg D, Paty PB, Picon AI, Guillem JG, Klimstra DS, Minsky BD, Quan SH, Cohen AM (1998) Stage I rectal cancer: identification of high-risk patients. J Am Coll Surg 186:574–579; (discussion 579–580) CrossRefGoogle Scholar
  2. Fujita S, Nakanisi Y, Taniguchi H, Yamamoto S, Akasu T, Moriya Y, Shimoda T (2007) Cancer invasion to Auerbach’s plexus is an important prognostic factor in patients with pT3-pT4 colorectal cancer. Dis Colon Rectum 50:1860–1866CrossRefGoogle Scholar
  3. Huh JW, Kim HR, Kim YJ (2010a) Lymphovascular or perineural invasion may predict lymph node metastasis in patients with T1 and T2 colorectal cancer. J Gastrointest Surg 14:1074–1080CrossRefGoogle Scholar
  4. Huh JW, Kim HR, Kim YJ (2010b) Prognostic value of perineural invasion in patients with stage II colorectal cancer. Ann Surg Oncol 17:2066–2072CrossRefGoogle Scholar
  5. Huh JW, Lee JH, Kim HR, Kim YJ (2013) Prognostic significance of lymphovascular or perineural invasion in patients with locally advanced colorectal cancer. Am J Surg 206:758–763CrossRefGoogle Scholar
  6. Knijn N, Mogk SC, Teerenstra S, Simmer F, Nagtegaal ID (2016) Perineural invasion is a strong prognostic factor in colorectal cancer: a systematic review. Am J Surg Pathol 40:103–112CrossRefGoogle Scholar
  7. Koelzer VH, Zlobec I, Lugli A (2016) Tumor budding in colorectal cancer–ready for diagnostic practice? Hum Pathol 47:4–19CrossRefGoogle Scholar
  8. Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, Agarwal N, Berger DH, Albo D (2009) Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol 27:5131–5137CrossRefGoogle Scholar
  9. Lim SB, Yu CS, Jang SJ, Kim TW, Kim JH, Kim JC (2010) Prognostic significance of lymphovascular invasion in sporadic colorectal cancer. Dis Colon Rectum 53:377–384CrossRefGoogle Scholar
  10. Minsky BD, Mies C, Rich TA, Recht A, Chaffey JT (1988) Potentially curative surgery of colon cancer: the influence of blood vessel invasion. J Clin Oncol 6:119–127CrossRefGoogle Scholar
  11. Oh BY, Park YA, Huh JW, Yun SH, Kim HC, Chun HK, Kim SH, Ha SY, Lee WY, Cho YB (2018) Prognostic impact of tumor-budding grade in stages 1–3 colon cancer: a retrospective Cohort study. Ann Surg Oncol 25:204–211CrossRefGoogle Scholar
  12. Ohtsuki K, Koyama F, Tamura T, Enomoto Y, Fujii H, Mukogawa T, Nakagawa T, Uchimoto K, Nakamura S, Nonomura A, Nakajima Y (2008) Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma. Anticancer Res 28:1831–1836PubMedGoogle Scholar
  13. Rogers AC, Gibbons D, Hanly AM, Hyland JM, O’Connell PR, Winter DC, Sheahan K (2014) Prognostic significance of tumor budding in rectal cancer biopsies before neoadjuvant therapy. Mod Pathol 27:156–162CrossRefGoogle Scholar
  14. Shinto E, Jass JR, Tsuda H, Sato T, Ueno H, Hase K, Mochizuki H, Matsubara O (2006) Differential prognostic significance of morphologic invasive markers in colorectal cancer: tumor budding and cytoplasmic podia. Dis Colon Rectum 49:1422–1430CrossRefGoogle Scholar
  15. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K (2002) Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2:573–583CrossRefGoogle Scholar
  16. Sternberg A, Amar M, Alfici R, Groisman G (2002) Conclusions from a study of venous invasion in stage IV colorectal adenocarcinoma. J Clin Pathol 55:17–21CrossRefGoogle Scholar
  17. Syk E, Lenander C, Nilsson PJ, Rubio CA, Glimelius B (2011) Tumour budding correlates with local recurrence of rectal cancer. Colorectal Dis 13:255–262CrossRefGoogle Scholar
  18. Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC (2002) Tumour ‘budding’ as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40:127–132CrossRefGoogle Scholar
  19. van Wyk HC, Park J, Roxburgh C, Horgan P, Foulis A, McMillan DC (2015) The role of tumour budding in predicting survival in patients with primary operable colorectal cancer: a systematic review. Cancer Treat Rev 41:151–159CrossRefGoogle Scholar
  20. Wang LM, Kevans D, Mulcahy H, O’Sullivan J, Fennelly D, Hyland J, O’Donoghue D, Sheahan K (2009) Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer. Am J Surg Pathol 33:134–141CrossRefGoogle Scholar
  21. Yuan H, Dong Q, Zheng B, Hu X, Xu JB, Tu S (2017) Lymphovascular invasion is a high risk factor for stage I/II colorectal cancer: a systematic review and meta-analysis. Oncotarget 8:46565–46579PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of SurgerySamsung Medical Center, Sungkyunkwan University School of MedicineSeoulSouth Korea

Personalised recommendations